Red Cell Management

Venture Capital Exempt reporting adviser

Legal name: Red Cell Management, LLC

Tysons, VA Website LinkedIn X

AUM

$245.7M
Private fund assets

Private funds

2
Venture Capital 2

Private fund assets

$245.7M
Gross asset value

Employees

—

Last Form D raise

Aug 2026
Most recent fund filing

From SEC Form ADV filing (filed Mar 24, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

G
Grant Verstandig
Chairman
Source: SEC Form ADV
J
John Tiernan
President
Source: SEC Form ADV
R
Roger Ferguson
Chief Executive Officer and Chief Investment Officer
Source: SEC Form ADV

Funds(2)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Red Cell Incubation Fund II, LPVenture Capital$60.4M$87.0M32Aug 2026Hot
Red Cell Incubation Fund, L.P.Venture Capital$185.3M——Dec 2023Cold

Board seats(2)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Andesite AI
OtherMcLean, VADirector: Grant Verstandig
$15.3M raised
Since Apr 2024
SEC Form D
Zephyr AI
BiotechnologyMcLean, VADirector: Grant Verstandig
$129.7M raised
Since Mar 2024
SEC Form D

Regulatory identifiers

CRD number
315048
SEC file number
802-132944

Sources